Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

PepHaūs vs PeptidesRx

By GLP-1 ScorecardUpdated

PepHaūs
Site position #27

Higher grade

PeptidesRx
Site position #265

Lower grade

Score comparison

PepHaūs has the higher recorded score — 82.7/100 to 64.4/100.

PepHaūs grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Verified and nationwide, but priced in the upper-mid band ($152/$246).

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valuePepHaūs +20
82
62
Dose & formulationPepHaūs +26
80
54
Clinical oversightPeptidesRx +1
84
85
Labs & monitoringPepHaūs +27
82
55
FulfillmentPepHaūs +16
86
70
Contract termsPepHaūs +30
85
55
PepHaūs · top barPeptidesRx · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricPepHaūsPeptidesRx
WeighScore82.7/10064.4/100
GradeB−C
Site position#27#265
Semaglutide$152/mo$169/mo (0.25 mg dose, compounded)
Tirzepatide$246/mo$309/mo (2.5 mg dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
PepHaūs

Site position #27 · B−

Strengths

  • LegitScript-verified, all 50 states
  • Both molecules
  • Transparent listed pricing

What to consider

  • Upper-mid pricing ($152/$246)
  • Injection-only
  • Monitoring detail limited
PeptidesRx

Site position #265 · C

Strengths

  • Compliance-focused positioning vs gray-market vendors
  • Board-certified medical director
  • Transparent pricing with no surprise fees
  • Real prescriptions, not research-chemical channel

What to consider

  • Smaller scale than Henry Meds or Hims
  • Wide peptide menu may distract from GLP-1 focus

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard